##plugins.themes.academic_pro.article.main##
Abstract
According to WHO, pharmacovigilance is defined as “science and activities relating to detection, assessment, understanding and prevention of adverse effects or any other drug related problem.[1]
WHO defines "Adverse Effect" as “any undesirable or unintended consequence of drug administration†[2].
The term Side Effect is often used synonymously but it precisely means unintended additional action of a drug which may even be therapeutically useful.
There is no drug without some or other adverse effect .It may develop either immediately or after prolonged use or even after stoppage of drug. Adverse effects are sometimes very rare. Even then, they play an important role in determining the therapeutic use of the drug.
It has been estimated that ADRs are responsible for death for nearly 50 out of every 1000 patients admitted to hospitals & cause nearly 5-7% of all hospital admissions.[3].The job of recording & studying these adverse effects is done by pharmacovigilance committee. Unfortunately, In India not all the clinicians & healthcare professionals are aware of this term and its importance.
This article enlightens the importance of pharmacovigilance among various health care professionals and some methods to increase its awareness.
Keywords—pharmacovigilance (PhV), adverse drug reactions(ADRs), side effects##plugins.themes.academic_pro.article.details##
References
2. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf.
3. http://www.newindianexpress.com/cities/hyderabad/%E2%80%985-pc-Hospital-Deaths-Due-to-ADR%E2%80%99/2014/10/28/article2496684.ece.
4. http://www.aiims.edu/aiims/departments/pharmacology/pvpi/pvmainfram.htm
5. Manoj Goyal, Monika Bansal, Shailesh Yadav, Varnika Grover, Preetkanwal :To assess the Attitude, knowledge and practices of medical professionals about Adverse drug reactions and their reporting in a teaching hospital. Indian J of Clinical Practice 2013; Vol. 24, No. 3, August . Available from: http://medind.nic.in /iaa/t13/i8/iaat13i8p281.pdf.
6. Hardeep, Jagminder Kaur Bajaj, and Kumar Rakesh;Survey on knowledge, attitude and practice of Pharmacovigilance among the health care professionals in teaching hospitals in northern India; Journal of Clinical and Diagnostic Research: JCDR 2013;7(1):97-99. doi:10.7860/JCDR/2012/4883. 2680.90. Available from: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC3576761/
7. Dhara Sanghavi;Impact of series of interventions On clinicians awareness about pharmacovigilance System in western India; Vol 7 Issue 3 (July-August) 2014 asian journalof pharmaceutical and clinical research. Available from: http://innovareacademics.in/journals/index.php/ajpcr/article /view/92.
8. Uchit GP, Shrivastava MP, Badar VA, Navale SB, Mayabhate MM:Adverse drug reactions to antimicrobial agents in a tertiary care hospital in Nagpur. J Indian Med Association. 2012 Apr;110(4):224 7.PMID:23025221 [PubMed - indexed for MEDLINE].
9. Edward H. Karl and Frederick A. Curro:A Case Report of Pharmacovigilance in Supporting Dentists and Participation in a Drug-Safety Program . Clinical Advances in PeriodonticsVol. 3: Issue. 1: Pages. 40-43(Volume publication date: February 2013). Available from:http://www.joponline.org/ doi/abs/10.1902/cap.2012.110007.
10. Madhanramesh And Gurumurthy Parthasarathi :Adverse drug reactions reporting: attitudes and perceptions of medical practitioners. Available from: http://www.ajpcr.com/Vol2Issue2/184.pdf.
11. ApproachAbideen PS, Chandrasekaran K, Uma Maheswaran, Vijayakumar A, Kalaiselvan V, et al.:Implementation of Self Reporting Pharmacovigilance in Anti Tubercular Therapy Using Knowledge Based. 2013; 1:101. doi: 10.4172/2329-6887.1000101 Available from: http://esciencecentral.org/journals/implementation-of-self-reporting-pharmacovigilance-in-anti-tubercular-therapy-using-knowledge-based-approach-2329-6887.1000101.pdf.
12. Prakash S. Masand, M.D., Sanjay Gupta, M.D., Thomas L. Schwartz, M.D., Subhdeep Virk, M.D., Ahmad Hameed, M.D., and David S. Kaplan M.D:Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome: A Pilot Study Available from: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1192434/.
13. XuezhangZhou, Yuyan Zhang, Yong Li, Xiujing Hao, Xiaoming Liu and Yujiong Wang: Azithromycin Synergistically Enhances Anti-Proliferative Activity of Vincristine in Cervical and Gastric Cancer Cells. 2012 Dec 4. Available from: (http://www.ncbi. nlm.nih.gov/pmc/articles/PMC3712727/).
14. Tomonori Kimura, Atsushi Takahashi and Yoshitaka Isaka: Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy ; The J of cancer research Nov 2,2012 . Available from: http://cancerres. aacrjournals.org/content/73/1/3.abstract.
15. Assadi f :Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.mar – apr 27 2006 Available from: http://www.ncbi. nlm.nih.gov/pubmed/1639198.